Incidence and Clinical Characteristics of Herpes Zoster After Lung Transplantation

Journal of Heart and Lung Transplantation

Volumn 27, Issue 1, 2008, Pages 11-16

  Manuel, Oriol ^a   Kumar, Deepali ^a   Singer, Lianne G ^b   Cobos, Isabel ^a   Humar, Atul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; GANCICLOVIR; PREDNISONE; VALGANCICLOVIR;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; INCIDENCE; INFECTION RISK; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTHERPETIC NEURALGIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SKIN INFECTION;

ADULT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CANADA; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HERPES ZOSTER; HERPES ZOSTER VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 37549000169     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.09.028     Document Type: Article

References (26)

1. Gnann Jr. J.W., and Whitley R.J. Herpes zoster. N Engl J Med 347 (2002) 340-346
2. Dworkin R.H., Johnson R.W., Breuer J., et al. Recommendations for the management of herpes zoster. Clin Infect Dis 44 suppl 1 (2007) S1-S26
3. Kost R.G., and Strauss S.E. Postherpetic neuralgia-pathogenesis, treatment, and prevention. N Engl J Med 335 (1996) 32-42
4. Gnann J.W. Herpes simplex and varicella-zoster virus infection after hemopoietic stem cell or solid organ transplantation. Transplant infections. 2nd ed. (2003), Lippincott-Raven 350-366
5. Gourishankar S., McDermid J.C., Jhangri G.S., and Preiksaitis J.K. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 4 (2004) 108-115
6. Carby M., Jones A., Burke M., Hall A., and Banner N. Varicella infection after heart and lung transplantation: a single-center experience. J Heart Lung Transplant 26 (2007) 399-402
7. Zamora M.R. Cytomegalovirus and lung transplantation. Am J Transplant 4 (2004) 1219-1226
8. Humar A., and Michaels M. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 6 (2006) 262-274
9. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant 15 (1996) 1-15
10. Cooper J.D., Billingham M., Egan T., et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 12 (1993) 713-716
11. Donahue J.G., Choo P.W., Manson J., and Platt R. The incidence of herpes zoster. Arch Intern Med 155 (1995) 1605-1609
12. Oxman M.N., Levin M.J., Johnson G.R., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 (2005) 2271-2284
13. Herrero J.I., Quiroga J., Sangro B., et al. Herpes zoster after liver transplantation: incidence, risk factors, and complications. Liver Transplant 10 (2004) 1140-1143
14. Levitsky J., Kalil A., Meza J.L., Hurst G.E., and Freifeld A. Herpes zoster infection after liver transplantation: a case-control study. Liver Transplant 11 (2005) 320-325
15. Helgason S., Petursson G., Gudmundsson S., and Sigurdsson J.A. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 321 (2000) 794-796
16. Jung B.F., Johnson R.W., Griffin D.R.J., and Dworkin R.H. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 62 (2004) 1545-1551
17. Lynfield R., Herrin J.T., and Rubin R.H. Varicella in pediatric renal transplant recipients. Pediatrics 90 (1992) 216-220
18. Feldhoff C.M., Balfour Jr. H.H., Simmons R.L., et al. Varicella in children with renal transplants. J Pediatr 98 (1981) 25-31
19. Pandya A., Wasfy S., Hebert D., and Allen U.D. Varicella-zoster infection in pediatric solid-organ transplant recipients: a hospital-based study in the prevaricella vaccine era. Pediatr Transplant 5 (2001) 153-159
20. Levitsky J., Kalil A.C., Meza J.L., et al. Chicken pox after pediatric liver transplantation. Liver Transplant 11 (2005) 1563-1566
21. Eisen H., Kobashigawa J., Keogh A., et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant 24 (2005) 517-525
22. Lauzurica R., Bayes B., Frias C., et al. Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc 35 (2003) 1758-1759
23. Rothwell W.S., Gloor J.M., Morgenstern B.Z., and Milliner D.S. Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil. Transplantation 68 (1999) 158-161
24. Fehr T., Bossart W., Wahl C., and Binswanger U. Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature. Transplantation 73 (2002) 608-611
25. Herpes simplex virus (HSV)-1 and -2, and varicella zoster virus (VZV). Am J Transplant 4 suppl 10 (2004) 69-71
26. Hata A., Asanuma H., Rinki M., et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 347 (2002) 26-34